Study: Newer hypertension drugs cut risk of diabetes

09/6/2006 | Reuters

A new analysis of a major European study indicates patients given a mix of newer blood pressure drugs are one-third less likely to develop diabetes than those on older medicines. The study compared a regimen of a beta blocker and a diuretic with a combination of Pfizer's more recent Norvasc, a calcium channel blocker, and Coversyl, an ACE inhibitor developed by France's Servier and marketed in the U.S. Aceon.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Chief Information Officer
Meridian Health Plan
Detroit, MI
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA